The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as
Cho-Kai Wu1, Chung-Yi Yang, Jou-Wei Lin
1Department of Internal Medicine, National Taiwan University College of Medicine and Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
Obesity (Silver Spring, Md.)
|March 12, 2011
Summary
Central obesity, measured by visceral adipose tissue (VAT), is linked to low-grade inflammation (C-reactive protein or CRP). This inflammation may cause subclinical left ventricular (LV) diastolic dysfunction in healthy adults.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Inflammation Research
Background:
- Central obesity is a growing health concern.
- Inflammation plays a role in cardiovascular disease.
- Subclinical left ventricular (LV) diastolic dysfunction can precede heart failure.
Purpose of the Study:
- To investigate the associations among central obesity, inflammation, and LV diastolic dysfunction.
- To explore the mediating role of inflammation in the relationship between central obesity and LV diastolic dysfunction using structural equation modeling.
Main Methods:
- Assessed echocardiographic parameters in 102 healthy adults over 30.
- Measured serum C-reactive protein (CRP) and lipid profiles.
- Quantified visceral adipose tissue (VAT) using CT scans and calculated HOMA for insulin resistance.
Main Results:
- Visceral adipose tissue (VAT) was significantly correlated with CRP (r=0.70, P<0.001).
- CRP was significantly associated with LV diastolic dysfunction (OR: 1.32, P=0.04).
- Structural equation modeling indicated VAT affects LV diastolic dysfunction via CRP (B=1.133, P<0.001), and CRP affects LV diastolic dysfunction (B=0.373, P<0.001).
Conclusions:
- Higher visceral adipose tissue (VAT) is associated with low-grade inflammation (CRP).
- This inflammation may lead to subclinical left ventricular (LV) diastolic dysfunction.
- Structural equation modeling confirms inflammation as a mediator between central obesity and LV diastolic dysfunction.
Related Concept Videos
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...


